Variation in Use of Androgen Suppression With External-Beam Radiotherapy for Nonmetastatic Prostate Cancer-Reference-Cited by-同舟云学术

Variation in Use of Androgen Suppression With External-Beam Radiotherapy for Nonmetastatic Prostate Cancer

Published:2012-05 Issue:1 Volume:83 Page:8-15
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Swisher-McClure Samuel,Pollack Craig E.,Christodouleas John P.,Guzzo Thomas J.,Haas Naomi B.,Vapiwala Neha,Bekelman Justin E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Studies on prostate cancer. 1. The effects of castration, or estrogen and androgen injection on serum phosphates in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial;Bolla;Lancet,2002

3. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate;Pilepich;Int J Radiat Oncol Biol Phys,2001

4. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial;D’Amico;JAMA,2004

5. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: Long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data;BMC Cancer;2022-06-07

2. The Treatments for Low-Risk Prostate Cancer;The Korean Journal of Urological Oncology;2019-04-30

3. The Treatments for Intermediate Risk Prostate Cancer;The Korean Journal of Urological Oncology;2019-04-30

4. Medication overuse in oncology: current trends and future implications for patients and society;The Lancet Oncology;2018-04

5. Overuse of Health Care Services in the Management of Cancer;Medical Care;2017-07